Effects of Remifentanil Pretreatment on Bupivacaine Cardiotoxicity in Rats

[1]  D. Calello,et al.  Systematic review of clinical adverse events reported after acute intravenous lipid emulsion administration , 2016, Clinical toxicology.

[2]  B. Mégarbane,et al.  Systematic review of the effect of intravenous lipid emulsion therapy for local anesthetic toxicity , 2016, Clinical toxicology.

[3]  G. Weinberg,et al.  A Review of Local Anesthetic Systemic Toxicity Cases Since Publication of the American Society of Regional Anesthesia Recommendations: To Whom It May Concern , 2015, Regional Anesthesia & Pain Medicine.

[4]  M. Saraf,et al.  In vitro relaxant and spasmolytic effects of essential oil of Pistacia integerrima Stewart ex Brandis Galls. , 2015, Journal of ethnopharmacology.

[5]  I. Sekler,et al.  A crosstalk between Na⁺ channels, Na⁺/K⁺ pump and mitochondrial Na⁺ transporters controls glucose-dependent cytosolic and mitochondrial Na⁺ signals. , 2015, Cell calcium.

[6]  Katsuya Tanaka,et al.  Opioid-induced cardioprotection. , 2014, Current pharmaceutical design.

[7]  D. Uncles,et al.  LIPAEMIC Report: Results of Clinical Use of Intravenous Lipid Emulsion in Drug Toxicity Reported to an Online Lipid Registry , 2014, Journal of Medical Toxicology.

[8]  Y. Oda,et al.  Effect of lipid emulsion on the central nervous system and cardiac toxicity of bupivacaine and levobupivacaine in awake rats , 2013, Journal of Anesthesia.

[9]  K. Kaya,et al.  Ropivacaine, articaine or combination of ropivacaine and articaine for epidural anesthesia in cesarean section: a randomized, prospective, double-blinded study. , 2013, Brazilian Journal of Anesthesiology.

[10]  M. Irwin,et al.  Remifentanil post‐conditioning attenuates cardiac ischemia–reperfusion injury via κ or δ opioid receptor activation , 2010, Acta anaesthesiologica Scandinavica.

[11]  American College of Medical Toxicology.  ACMT Position Statement: Interim Guidance for the Use of Lipid Resuscitation Therapy , 2010, Journal of Medical Toxicology.

[12]  J. Shim,et al.  Remifentanil protects myocardium through activation of anti-apoptotic pathways of survival in ischemia-reperfused rat heart. , 2010, Physiological research.

[13]  J. Neal,et al.  Clinical Presentation of Local Anesthetic Systemic Toxicity: A Review of Published Cases, 1979 to 2009 , 2009, Regional Anesthesia & Pain Medicine.

[14]  J. Neal,et al.  ASRA Practice Advisory on Local Anesthetic Systemic Toxicity , 2009, Regional Anesthesia & Pain Medicine.

[15]  G. Weinberg.  Treatment of Local Anesthetic Systemic Toxicity (LAST) , 2009, Regional Anesthesia & Pain Medicine.

[16]  V. Hancı,et al.  Effects of Dexmedetomidine Pretreatment on Bupivacaine Cardiotoxicity in Rats , 2009, Regional Anesthesia & Pain Medicine.

[17]  Kristen Felice,et al.  Intravenous lipid emulsion for local anesthetic toxicity: A review of the literature , 2008, Journal of Medical Toxicology.

[18]  S. Stehr,et al.  Reversal of central nervous system and cardiac toxicity after local anesthetic intoxication by lipid emulsion injection. , 2008, Anesthesia and analgesia.

[19]  M. Irwin,et al.  Remifentanil preconditioning confers delayed cardioprotection in the rat. , 2007, British journal of anaesthesia.

[20]  J. Eisenkraft,et al.  Successful use of a 20% lipid emulsion to resuscitate a patient after a presumed bupivacaine-related cardiac arrest. , 2006, Anesthesiology.

[21]  M. Irwin,et al.  Remifentanil mimics cardioprotective effect of ischemic preconditioning via protein kinase C activation in open chest of rats , 2005, Acta Pharmacologica Sinica.

[22]  G. Gross,et al.  Opioid-induced preconditioning: recent advances and future perspectives. , 2005, Vascular pharmacology.

[23]  M. Irwin,et al.  Remifentanil Preconditioning Confers Cardioprotection via Cardiac κ- and δ-Opioid Receptors , 2005 .

[24]  M. Irwin,et al.  Remifentanil preconditioning confers cardioprotection via cardiac kappa- and delta-opioid receptors. , 2005, Anesthesiology.

[25]  L. Groban.  Central Nervous System and Cardiac Effects From Long-Acting Amide Local Anesthetic Toxicity in the Intact Animal Model , 2002, Regional Anesthesia & Pain Medicine.

[26]  F. Bonnet,et al.  Asystole during anaesthetic induction with remifentanil and sevoflurane. , 2001, British journal of anaesthesia.

[27]  B. Finucane,et al.  Complications of regional anaesthesia Incidence and prevention. , 2001, Drug safety.

[28]  B. Shin,et al.  Insulin Reverses Bupivacaine-Induced Cardiac Depression in Dogs , 2000, Anesthesia and analgesia.

[29]  R. Mirakhur,et al.  Bradycardia after administration of remifentanil. , 2000, British journal of anaesthesia.

[30]  S Howell,et al.  A review of the pharmacokinetics and pharmacodynamics of remifentanil. , 1999, Anesthesia and analgesia.

[31]  G. Weinberg,et al.  Pretreatment or Resuscitation with a Lipid Infusion Shifts the Dose‐Response to Bupivacaine‐induced Asystole in Rats , 1998, Anesthesiology.

[32]  J. Brugada,et al.  [Cardiotoxicity of local anesthetics]. , 1993, Cahiers d'anesthesiologie.

[33]  C. Lynch.  Depression of Myocardial Contractility In Vitro by Bupivacaine, Etidocaine, and Lidocaine , 1986, Anesthesia and analgesia.

[34]  L. Hondeghem,et al.  Mechanism for Bupivacaine Depression of Cardiac Conduction: Fast Block of Sodium Channels during the Action Potential with Slow Recovery from Block during Diastole , 1985, Anesthesiology.

[35]  B. Covino,et al.  Acute Cardiovascular Toxicity of Intravenous Amide Local Anesthetics in Anesthetized Ventilated Dogs , 1982, Anesthesia and analgesia.